MICHELLE BOONE: Open Payments
NPI 1023503042 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 23 payments from 11 companies in 2025. Trend: 2023 $1,426 · 2024 $4,055 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 7 | $164 |
| Abbott Laboratories | 1 | $141 |
| Globus Medical, Inc. | 5 | $141 |
| Averitas Pharma Inc. | 1 | $94 |
| SI-BONE, INC. | 1 | $88 |
| Boston Scientific Corporation | 1 | $56 |
| PROTEGA PHARMACEUTIALS INC | 2 | $50 |
| Saluda Medical Americas, Inc. | 1 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Radius Health, Inc. | 1 | $29 |
Products named: PROCLAIM, Senza, Belbuca, QUTENZA, Intracept, ROXYBOND, Evoke, RELISTOR.
Industry payments across IN — which companies pay providers there.
